2 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Mission Pharmacal: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Proof of Concept Study in Uncomplicated UTI MPC-SHRC, Placebo Oral Tablet - Urinary Tract Infections | Phase 2 | Unknown | Mission Pharmacal | 200 | 2017-04-01 | 2017-04-26 |
| Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy placebo, MPC-5971 - Nephrolithiasis | Phase 2 | Terminated | Mission Pharmacal | 135 | 2010-04-01 | 2019-03-07 |
| Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study tinidazole, Placebo - Bacterial Vaginosis | Early Phase 1 | Completed | University of Pittsburgh | 37 | 2007-10-01 | 2011-02-18 |
| Treatment of Bacterial Vaginosis With Oral Tinidazole Tinidazole - Bacterial Vaginosis | Phase 3 | Completed | Mission Pharmacal | 200 | 2005-01-01 | 2017-03-22 |
Vaginosis, Bacterial (2) · Kidney Calculi (1) · Nephrolithiasis (1) · Urinary Tract Infections (1) · Urolithiasis (1)
Tinidazole (2)
United States (4)
Margaret E. Hurley, MD (1) · Richard Beigi, MD, MSc. (1)